Tag Archives: EBIX

Top 10 Tech Stocks To Invest In 2021

Red Robin (NASDAQ:RRGB) was the target of some unusual options trading on Thursday. Traders bought 2,155 put options on the stock. This represents an increase of approximately 790% compared to the average volume of 242 put options.

NASDAQ:RRGB opened at $48.00 on Friday. The firm has a market cap of $614.85 million, a price-to-earnings ratio of 19.28, a P/E/G ratio of 1.88 and a beta of 0.30. Red Robin has a 1 year low of $45.70 and a 1 year high of $73.75. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 0.61.

Get Red Robin alerts:

Red Robin (NASDAQ:RRGB) last posted its earnings results on Tuesday, May 22nd. The restaurant operator reported $0.69 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.07). The company had revenue of $421.50 million for the quarter, compared to analysts’ expectations of $427.01 million. Red Robin had a return on equity of 7.80% and a net margin of 1.65%. The company’s revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.89 EPS. analysts predict that Red Robin will post 2.61 earnings per share for the current fiscal year.

Top 10 Tech Stocks To Invest In 2021: Allscripts Healthcare Solutions, Inc.(MDRX)

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The companys Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. It has a strategic partnership with Nant Health, LLC. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Advisors’ Opinion:

  • [By Max Byerly]

    Allscripts Healthcare Solutions (NASDAQ:MDRX) and Convergys (NYSE:CVG) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

  • [By Brian Feroldi]

    In response to announcing fourth-quarter results, shares ofAllscriptsHealthcare Solutions(NASDAQ:MDRX),a healthcare information technology company, fell 11% as of 3:25 p.m. EST on Friday.

  • [By Motley Fool Transcribers]

    Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)Q42018 Earnings Conference CallFeb. 21, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Tech Stocks To Invest In 2021: Exterran Corporation(EXTN)

Exterran Corporation engages in the compression, production, and processing of various products and services for the oil and natural gas industry worldwide. The company operates through three segments: Contract Operations, Aftermarket Services, and Product Sales. The Contract Operations segment provides contract operations services, including provision of personnel, equipment, tools, materials, and supplies. The Aftermarket Services segment sells parts and components; and provides operation, maintenance, overhaul, and reconfiguration services, as well as integrated infrastructure solutions. The Product Sales segment designs, engineers, manufactures, sells, and installs a range of oil and natural gas production and processing equipment designed to heat, separate, dehydrate, and condition crude oil and natural gas. Its products include line heaters, oil and natural gas separators, glycol dehydration units, condensate stabilizers, dew point control plants, water treatment, mechanical refrigeration, and cryogenic plants and skid-mounted production packages designed for onshore and offshore production facilities. This segment also sells custom-engineered and built-to-specification production and processing equipment, including designing facilities. In addition, it provides engineering, procurement, and manufacturing services related to the manufacture of critical process equipment for refinery and petrochemical facilities, tanks for tank farms and evaporators, and brine heaters for desalination plants. The company was founded in 2007 and is headquartered in Houston, Texas.

Advisors’ Opinion:

  • [By Ethan Ryder]

    BlackRock Inc. increased its position in shares of Exterran Corp (NYSE:EXTN) by 5.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,885,496 shares of the energy company’s stock after buying an additional 244,903 shares during the quarter. BlackRock Inc. owned 0.14% of Exterran worth $122,333,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Exterran (EXTN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Robotti Robert lowered its holdings in Exterran Corp (NYSE:EXTN) by 0.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 365,072 shares of the energy company’s stock after selling 2,670 shares during the quarter. Exterran accounts for about 2.4% of Robotti Robert’s investment portfolio, making the stock its 13th largest position. Robotti Robert’s holdings in Exterran were worth $9,141,000 at the end of the most recent quarter.

Top 10 Tech Stocks To Invest In 2021: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer’s disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors’ Opinion:

  • [By ]

    Just last Thursday, March 21, Biogen (Nasdaq: BIIB) and its partner, Japanese biopharmaceutical company Eisai (OTC: ESALY), said that their experimental Alzheimer’s therapy, which at that time was at the second stage of clinical trials, was a bust. BIIB dropped 29.2% on the day, and ESALY by 35% on the same day.

  • [By Chris Hill]

    In this episode ofMotley Fool Money, host Chris Hill and analysts Emily Flippen, Jim Mueller, and Jason Moser hit on some of the biggest recent news in the market. Disney (NYSE:DIS)finishes up its merger with Fox, and it’s ready to take on a crowded streaming space. CVS Health(NYSE:CVS) diversifies into CBD lotion. Levi Strauss(NYSE:LEVI) enters the public markets with a bafflingly high market cap, while Nike (NYSE:NKE)sells off on higher-than-expected revenue and profits. Biogen’s (NASDAQ:BIIB) biggest trial bombs, and the stock tanks along with it. Papa John’s(NASDAQ:PZZA) welcomes Shaq into its board of directors. And, as always, the analysts share some stocks on their radar. Plus, stay tuned for an interview with Lake House Capital’s Joe Magyer about investing in Australia — the biggest trends, biggest worries, and some Aussie picks to add to your watch list.

Top 10 Tech Stocks To Invest In 2021: Facebook, Inc.(FB)

Facebook, Inc. operates as a mobile application and Website that enables people to connect, share, discover, and communicate each other on mobile devices and personal computers worldwide. Its solutions also include Instagram, a mobile application that enables people to take photos or videos, customize them with filter effects, and share them with friends and followers in a photo feed or send them directly to friends; Messenger, a messaging application for mobile and Web on various platforms and devices, which enable people to reach others instantly, as well as enable businesses to engage with customers; and WhatsApp Messenger, a mobile messaging application. The company also develops Oculus virtual reality technology and content platform, which allow people to enter an immersive and interactive environment to play games, consume content, and connect with others. As of December 31, 2015, it had 1.04 billion daily active users (DAUs) and 934 million DAUs who accessed Facebook from a mobile device. Facebook, Inc. was founded in 2004 and is headquartered in Menlo Park, California.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Facebook Inc (NASDAQ:FB)Q12019 Earnings CallApril 24, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    With major S&P 500 companies from Facebook (Nasdaq: FB) to Netflix (Nasdaq: NFLX) now reassigned, the change is simply too big to be ignored. That goes for passive investors — ones who rely on an index-tracking approach — and active investors like us who frequently screen sectors and indices for ideas.

  • [By ]

    More impressively, Tran accomplished this without hiring a single salesperson or spending a cent on advertising. Even today, his company doesn’t have a Twitter (Nasdaq: TWTR) handle or Facebook (Nasdaq: FB) account.

  • [By Money Morning News Team]

    The site is completely free to use, but you need an account to get moving. Luckily, Pinterest makes this simple by allowing you to integrate your Google and Facebook Inc. (NASDAQ: FB) logins.

Top 10 Tech Stocks To Invest In 2021: Cabot Microelectronics Corporation(CCMP)

Cabot Microelectronics Corporation develops, manufactures, and sells polishing slurries and pads used in the manufacture of advanced integrated circuit (IC) devices in the semiconductor industry in a process called chemical mechanical planarization (CMP). The CMP technology is a polishing process used by IC device manufacturers to planarize or flatten the multiple layers of material that are deposited upon silicon wafers. The company offers CMP slurries, which are liquid solutions composed of high-purity deionized water, proprietary chemical additives, and engineered abrasives that chemically and mechanically interact with the surface material of the IC device at an atomic level; and CMP pads that are engineered polymeric materials designed to distribute and transport the slurry to the surface of the wafer and distribute it evenly across the wafer. Its CMP slurries are used for polishing various materials that conduct electrical signals, including tungsten, copper, tantalum, and aluminum; and certain materials that are used in the production of rigid disks and magnetic heads for hard disk drives, as well as used in the dielectric insulating materials that separate conductive layers within logic and memory IC devices. The company also designs and produces precision polishing and metrology systems to attain near-perfect shape and surface finish on various optical components, such as mirrors, lenses, and prisms. It serves the producers of logic IC devices or memory IC devices, and providers of IC foundry services. The company operates in the United States, Asia, and Europe. Cabot Microelectronics Corporation was founded in 1999 and is headquartered in Aurora, Illinois.

Advisors’ Opinion:

  • [By Joseph Griffin]

    News coverage about Cabot Microelectronics (NASDAQ:CCMP) has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cabot Microelectronics earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.640513544039 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Ethan Ryder]

    Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $112.25.

  • [By Max Byerly]

    Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $114.80.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cabot Microelectronics (CCMP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Tech Stocks To Invest In 2021: Ebix, Inc.(EBIX)

Ebix, Inc. (Ebix), incorporated on December 29, 2003, is a supplier of software and e-commerce solutions to the insurance, finance and healthcare industries. The Company provides application software products for the insurance industry, including carrier systems, agency systems and exchanges, as well as custom software development. The Company conducts its operations through four channels, which include Exchanges, Carrier Systems, Broker Systems and Risk Compliance Solutions (RCS). Ebix operates data exchanges in the areas of life insurance, annuities, employee health benefits, risk management, workers compensation, and property and casualty (P&C) insurance. Ebix’s focus in the area of broker systems is on designing and deploying back-end systems for international P&C insurance brokers across the world. Ebix’s focus in the area of carrier systems is on designing and deploying on-demand and back-end systems for P&C insurance companies. Ebix focus in RCS channel pertains to business process outsourcing services that include providing domain intensive project management, time and material consulting to clients across the world, and claims adjudication/settlement services, in addition to the creation and tracking of certificates of insurance issued in the United States and Australian markets. Ebix also provides software development, customization and consulting services to various entities in the insurance industry, including carriers, brokers, exchanges and standard making bodies.

Exchanges

The Company’s data exchanges connect various entities within the insurance markets enabling the participant to carry and process data from one end to another. Its life, annuity and employee health benefit exchanges operate primarily in the United States, while the P&C exchanges operates primarily in Australia, New Zealand, the United Kingdom and Brazil. Ebix operates a processing end-to-end Life Exchange service that has over three life insurance exchanges in the United States, such as Winfle! x, TPP and LifeSpeed. Winflex is an exchange for pre-sale life insurance illustrations between brokers and carriers; TPP is an underwriting and customized electronic application platform for Life insurance, and LifeSpeed is an order entry platform for life insurance. Ebix operates a processing end-to-end Annuity Exchange service that has over three life insurance exchanges in the United States, such as Annuitynet, AMP and AN4. The Company’s exchanges are platforms for annuity transactions between brokers, carriers, broker general agents (BGA’s) and other entities involved in annuity transactions. Ebix’s customer relationship management (CRM) exchange, SmartOffice, is designed for insurance companies, general agents, banks, financial advisors and investment dealers. Smart Office is integrated into EbixExchange Life, Health, P&C and Annuity exchanges.

The Company provides employee benefit and health insurance exchange services using over four platforms, such as Facts, LumininX, HealthConnect and EbixEnterprise. Ebix’s platforms are sold to health carriers and third party administrators. The platforms provide a range of services, such as employee enrollment, claims adjudication, accounting, employee benefits administration accounting and compliance. The HealthConnect insurance quoting portals service the individual and small group marketplace. Through A.D.A.M. Health Solutions, Ebix provides multimedia health content, training, patient education and continuing education for various Websites, doctors, consumer health portals, country governments, hospitals, healthcare, biomedical, medical device, pharmaceutical and education organizations. Ebix operates P&C exchanges in Australia, New Zealand, the United Kingdom and the United States.

The Company competes with iPipeline, Salesforce.com, Redtail, Trizetto, BenefitFocus, Ultimate Software, Krames Staywell, Red Nucleus and Anatomy One.

Broker P&C Systems

The Company offers a number of broker system offerings ! for P&C b! rokers across the world, which include eGlobal, which targets multinational P&C insurance brokers; WinBeat, which targets P&C brokers in the Australian and New Zealand markets, and EbixASP, which is a system for the P&C insurance brokers in the United States. eGlobal is multilingual and multicurrency, and is available in various languages, such as English, Chinese, Japanese, French, Portuguese and Spanish. EbixASP is designed around the Association for Cooperative Operations Research and Development (ACORD) insurance standards used in the United States. The Company’s main focus in the broker systems channel is on markets outside the United States.

The Company competes with Lumley, SSP, Vertafore, Applied Systems and XDimensional.

Risk Compliance Solutions

The Company’s RCS channel focuses on helping its clients outsource any specific service or manpower to the Company on an onsite or offshore basis. Ebix’s RCS certificate outsourcing business services are enabled by the Company’s software as a service (SaaS)-based software. Ebix’s RCS service offerings cater to a number of companies in the United States. Ebix provides a software-based service for issuance of certificates of insurance that adheres to industry standards, such as ACORD.

The Company competes with Applied Systems, Datamonitor, CMS and Exigis.

Carrier P&C Systems

The Company has various carrier system offerings for P&C carriers, such as Ebix Advantage and Ebix AdvantageWeb. Ebix Advantage is targeted at P&C carriers in the United States that operate in the personal, commercial and specialty line areas of insurance. Ebix AdvantageWeb is designed for the international markets, and is targeted at the small, medium and large P&C carriers in the international markets that operate in the personal, commercial and specialty line areas of insurance. Ebix AdvantageWeb is designed to be multicurrency and multilingual, and is deployed in Brazil, the United Kingdom and the Unite! d States.!

The Company competes with CSC, Guidewire, Xchanging, Accenture and Delphi.

Advisors’ Opinion:

  • [By Logan Wallace]

    COPYRIGHT VIOLATION WARNING: “Ebix Inc (EBIX) Holdings Cut by Royce & Associates LP” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at www.tickerreport.com/banking-finance/4220018/ebix-inc-ebix-holdings-cut-by-royce-associates-lp.html.

  • [By Rich Smith]

    Shares of Indian travel website Yatra Online (NASDAQ:YTRA) surged roughly 31% Monday after on-demand software company Ebix (NASDAQ:EBIX) — which earlier this month reported strong sales growth but drastically reduced profits — launched an effort to diversify its business by making an offer to buy Yatra.

  • [By Motley Fool Transcribers]

    Ebix Inc (NASDAQ:EBIX)Q42018 Earnings Conference CallMarch 01, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Shares of Ebix Inc (NASDAQ:EBIX) were down 5.8% during mid-day trading on Tuesday . The stock traded as low as $57.66 and last traded at $61.47. Approximately 18,499 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 189,931 shares. The stock had previously closed at $58.10.

Top 10 Tech Stocks To Invest In 2021: Cellcom Israel Ltd.(CEL)

Cellcom Israel Ltd. provides cellular communications services in Israel. It offers basic and advanced cellular telephone services, text and multimedia messaging services, and advanced cellular content and data services. The company?s basic cellular telephony services include voice mail, cellular fax, call waiting, call forwarding, caller identification, collect call, conference calling, ?Talk 2?, additional number services, and collect call services; and outbound and inbound roaming services. It also provides value-added services comprising Cellcom volume that includes downloadable content, such as music, games, on-net-reality programs, drama series, and video games; SMS and MMS services to send and receive text, photos, multimedia, and animation messages; access to third party application providers for notification of roadway speed detectors, mange vehicle fleets, and enable subscribers to manage and operate time clocks and various controllers for industrial, agricultural , and commercial purposes; video calls to communicate with each other through video applications; zone services for calls initiated from a specific location; location-based services; voice-based information services; text-based information services and interactive information services, including news headlines, sports results, and traffic and weather reports; and data services to access handsets, cellular modems, laptops, tablets, and cellular routers, as well as Internet based payment services. In addition, the company sells handsets, modems, routers, tablets, and laptops, as well as provides repair and replacement services; and offers landline telephony, transmission, and data services through its approximately 1,500 kilometers of inland fiber-optic infrastructure and complementary microwave links to selected business customers. As of March 31, 2011, it provided its services to approximately 3.395 million subscribers. The company was founded in 1994 and is headquartered in Netanya, Israel.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Hellenic Telecom Organization (NYSE: CEL) and Cellcom Israel (NYSE:CEL) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

  • [By Stephan Byrd]

    Partner Communications (NASDAQ: PTNR) and Cellcom Israel (NYSE:CEL) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

  • [By Ethan Ryder]

    Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

Top 10 Tech Stocks To Invest In 2021: Yingli Green Energy Holding Company Limited(YGE)

Yingli Green Energy Holding Company Limited, together with its subsidiaries, designs, develops, markets, manufactures, sells, and installs photovoltaic (PV) products in the Peoples Republic of China and internationally. The company offers polysilicon ingots and blocks, polysilicon wafers, PV cells, PV modules, and integrated PV systems; and develops and operates solar projects. It primarily sells its PV modules to distributors, wholesalers, power plant developers and operators, and PV system integrators under the brand names Yingli and Yingli Solar. Yingli Green Energy Holding Company Limited was founded in 1998 and is headquartered in Baoding, the Peoples Republic of China.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Yingli Green Energy (NYSE:YGE) had its target price raised by S&P Equity Research from $0.45 to $0.62 in a research report released on Tuesday morning.

  • [By Ethan Ryder]

    Yingli Green Energy (NYSE: YGE) and Netlist (NASDAQ:NLST) are both small-cap oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

Top 10 Tech Stocks To Invest In 2021: Qualys, Inc.(QLYS)

Qualys, Inc. provides cloud-based security and compliance solutions in the United States and internationally. The company offers Qualys Cloud Suite, which includes Vulnerability Management, Policy Compliance, PCI Compliance, Web Application Scanning, Malware Detection Service, Web Application Firewall, and Qualys SECURE Seal. Its integrated suite of security and compliance solutions delivered on its Qualys Cloud Platform enables customers to identify their IT assets, collect and analyze large amounts of IT security data, discover and prioritize vulnerabilities, recommend remediation actions, and verify the implementation of such actions. It also provides core services, including asset tagging and management, reporting and dashboards, questionnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications, which enable integrated workflows, management and real-time analysis, and reporting across IT security and compliance solutions. In addition, the company offers cloud infrastructure services that include the data, data processing capabilities, software and hardware infrastructure, and infrastructure management capabilities. Qualys, Inc. markets and sells its IT security and compliance solutions to customers directly through its sales teams, as well as indirectly through its network of channel partners, such as security consulting organizations, managed service providers, value added resellers, and consulting firms. It serves enterprises, government entities, and small and medium-sized businesses in various industries, including education, financial services, government, healthcare, insurance, manufacturing, media, retail, technology, and utilities. The company was founded in 1999 and is headquartered in Redwood City, California.

Advisors’ Opinion:

  • [By Jon C. Ogg]

    QualysInc. (NASDAQ: QLYS) was up 1.7% at $96.41 ahead of earnings, but the guidance had the shares down almost 16% at $81.00 on Wednesday morning. JPMorgandowngradedit to Underweight from Neutral and cut the price target to $82 from $90. Wedbushmaintained its Outperform rating with a $95 price target, but noted that guidance was nothing to write home about and addresses whether guidance was conservative or if there is a slowing demand.

  • [By Shane Hupp]

    TRADEMARK VIOLATION WARNING: “Stock Traders Buy Large Volume of Qualys Call Options (QLYS)” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at www.tickerreport.com/banking-finance/4147960/stock-traders-buy-large-volume-of-qualys-call-options-qlys.html.

Top 10 Tech Stocks To Invest In 2021: Five9, Inc.(FIVN)

Five9 is a pioneer and leading provider of cloud software for contact centers. Since our inception, we have exclusively focused on delivering our platform in the cloud and are disrupting a significantly large market by replacing legacy on-premise contact center systems. Contact centers are vital hubs of interaction between organizations and their customers and, therefore, are essential to delivering successful customer service, sales and marketing strategies. Our mission is to empower organizations to transform their contact centers into customer engagement centers of excellence, while improving business agility and significantly lowering the cost and complexity of their contact center operations. Our purpose-built, highly scalable and secure Virtual Contact Center (“VCC”) cloud platform delivers a comprehensive suite of easy-to-use applications that enable the breadth of contact center-related customer service, sales and marketing functions.   Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Five9 (FIVN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Five9 Inc (NASDAQ:FIVN)Q42018 Earnings Conference CallFeb. 19, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Here are some of the news stories that may have effected Accern’s rankings:

    Get MDU Resources Group alerts:

    MDU Resources Group, Inc. (MDU): Stock Trending Alert (thenewsbloom.org) These Stocks’s might change the Kismet of Investors: Five9, Inc. (NASDAQ:FIVN), MDU Resources Group, Inc. (NYSE … (journalfinance.net) Is this stock Watchful?: MDU Resources Group, Inc. (MDU), Dover Downs Gaming & Entertainment, Inc. (DDE) (newsregistrar.com) MDU Resources Group, Inc. (MDU) crosses above SMA-50 with 0.40% (nasdaqplace.com)

    NYSE MDU opened at $28.48 on Tuesday. The stock has a market cap of $5.59 billion, a PE ratio of 22.10, a price-to-earnings-growth ratio of 3.17 and a beta of 0.64. The company has a current ratio of 1.39, a quick ratio of 1.05 and a debt-to-equity ratio of 0.71. MDU Resources Group has a one year low of $24.29 and a one year high of $29.62.

Top 5 Performing Stocks For 2019

With the Nasdaq breaching the 7,000 barrier one can safely say that this was a year when tech stocks really came into their own. To put things in perspective, the Technology Select Sector SPDR is up nearly 35% year to date, easily outperforming its closest peers by nearly 15%.

Source: Shutterstock

Most of the recent equity market rally can be attributed to a small clutch of stocks, namely the FAAMG group and Netflix, Inc. (NASDAQ:NFLX). Of these, only Alphabet Inc (NASDAQ:GOOGL) is up 37% year to date while all the others, including iPhone maker Apple Inc. (NASDAQ:AAPL) are up more than 50% over the same period.

Top 5 Performing Stocks For 2019: TechTarget, Inc.(TTGT)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of TechTarget (NASDAQ:TTGT) fell as much as 27% lower this morning, recovering to a milder 18% decline as of 11:45 a.m. EDT. The provider of online marketing and sales services beat analyst estimates across the board in Wednesday night’s second-quarter report, but the surprises weren’t big enough to sustain TechTarget’s skyrocketing market momentum today.

  • [By Ethan Ryder]

    TechTarget Inc (NASDAQ:TTGT)’s share price was up 5.3% on Tuesday . The company traded as high as $24.56 and last traded at $24.31. Approximately 572,168 shares were traded during trading, an increase of 76% from the average daily volume of 325,794 shares. The stock had previously closed at $23.08.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TechTarget (TTGT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks For 2019: Cincinnati Bell Inc(CBB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Laurion Capital Management LP purchased a new stake in shares of Cincinnati Bell Inc. (NYSE:CBB) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 44,180 shares of the utilities provider’s stock, valued at approximately $694,000. Laurion Capital Management LP owned about 0.09% of Cincinnati Bell at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cincinnati Bell (CBB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Friday was mixed on Wall Street, with the Nasdaq Composite eking out minor gains even as most other major benchmarks finished down modestly. Market participants seemed largely content to see how things played out on the geopolitical front between the U.S. and North Korea, and key reversals in other financial markets helped send 10-year Treasury rates back below 3% and also resulted in a substantial drop in crude oil prices. Despite generally quiet conditions, bad news sent shares of certain companies lower. Accuray (NASDAQ:ARAY), Cincinnati Bell (NYSE:CBB), and Chesapeake Energy (NYSE:CHK) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Stephan Byrd]

    Cincinnati Bell (NYSE:CBB) last issued its quarterly earnings data on Wednesday, May 9th. The utilities provider reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.04). Cincinnati Bell had a negative net margin of 2.77% and a negative return on equity of 0.61%. The company had revenue of $296.00 million for the quarter, compared to the consensus estimate of $296.69 million. During the same quarter last year, the business posted ($0.01) earnings per share. Cincinnati Bell’s revenue was up 6.5% on a year-over-year basis. sell-side analysts forecast that Cincinnati Bell Inc. will post -0.66 earnings per share for the current fiscal year.

  • [By Ethan Ryder]

    An issue of Cincinnati Bell Inc. (NYSE:CBB) bonds fell 0.8% as a percentage of their face value during trading on Thursday. The high-yield debt issue has a 7% coupon and will mature on July 15, 2024. The debt is now trading at $89.25 and was trading at $90.25 one week ago. Price moves in a company’s bonds in credit markets often predict parallel moves in its stock price.

Top 5 Performing Stocks For 2019: Zillow Group, Inc.(ZG)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Shares of Zillow Group, Inc. (NASDAQ:Z) (NASDAQ:ZG) sold off last month as the market expressed dissatisfaction with the company’s plan to flip houses. As a result, both classes of stock closed April down around 10%, according to data from S&P Global Market Intelligence.

  • [By Joseph Griffin]

    Verition Fund Management LLC acquired a new stake in shares of Zillow Group Inc Class A (NASDAQ:ZG) in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 13,876 shares of the technology company’s stock, valued at approximately $749,000.

  • [By Jim Crumly]

    As for individual stocks, Zillow (NASDAQ:Z) (NASDAQ:ZG) fell slightly after the company reported earnings, while Camping World Holdings (NYSE:CWH) plunged on first-quarter results.

Top 5 Performing Stocks For 2019: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Ebix Inc (NASDAQ:EBIX) were down 5.8% during mid-day trading on Tuesday . The stock traded as low as $57.66 and last traded at $61.47. Approximately 18,499 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 189,931 shares. The stock had previously closed at $58.10.

  • [By Rich Smith]

    Shares of Indian travel website Yatra Online (NASDAQ:YTRA) surged roughly 31% Monday after on-demand software company Ebix (NASDAQ:EBIX) — which earlier this month reported strong sales growth but drastically reduced profits — launched an effort to diversify its business by making an offer to buy Yatra.

  • [By Ethan Ryder]

    Ebix (NASDAQ:EBIX) issued its earnings results on Wednesday. The technology company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.01), MarketWatch Earnings reports. The business had revenue of $108.23 million for the quarter, compared to analysts’ expectations of $106.81 million. Ebix had a return on equity of 20.67% and a net margin of 27.65%. Ebix’s revenue for the quarter was up 36.8% on a year-over-year basis.

  • [By Shane Hupp]

    ARS Investment Partners LLC boosted its position in shares of Ebix Inc (NASDAQ:EBIX) by 62.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92,910 shares of the technology company’s stock after acquiring an additional 35,681 shares during the quarter. ARS Investment Partners LLC owned 0.30% of Ebix worth $6,922,000 at the end of the most recent quarter.

Top 5 Performing Stocks For 2019: Surgery Partners, Inc.(SGRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Tenet Healthcare (NYSE: THC) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations.

  • [By Max Byerly]

    Surgery Partners Inc (NASDAQ:SGRY) has been assigned a consensus recommendation of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $19.40.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Surgery Partners (SGRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Watch For 2019

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits) to value at $26.81 for the said trading session. Since we recommended the company on Nov. 27, 2017 (just over a month) to subscribers of Integrated BioSci Investing, the stock added another $7.26 (or 37% in capital appreciation). This robust run-up is interesting because, on Jan. 04, 2018, the company announced that the 5M additional common shares issued on Jan 03 will be priced at $22.75.

Top 10 Undervalued Stocks To Watch For 2019: Internap Network Services Corporation(INAP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Internap (NASDAQ:INAP) issued its quarterly earnings data on Thursday. The information technology services provider reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.13), MarketWatch Earnings reports. The business had revenue of $74.20 million for the quarter, compared to analyst estimates of $73.99 million. Internap had a negative return on equity of 271.76% and a negative net margin of 16.15%. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.02) earnings per share.

  • [By Shane Hupp]

    GDS (NASDAQ: INAP) and Internap (NASDAQ:INAP) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Internap (INAP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Shares of Internap Corp (NASDAQ:INAP) saw unusually-strong trading volume on Tuesday . Approximately 1,086,029 shares traded hands during mid-day trading, an increase of 306% from the previous session’s volume of 267,673 shares.The stock last traded at $5.85 and had previously closed at $5.32.

  • [By Stephan Byrd]

    Internap Corp (NASDAQ:INAP) has received an average rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $28.00.

Top 10 Undervalued Stocks To Watch For 2019: KLX Inc.(KLXI)

Advisors’ Opinion:

  • [By Logan Wallace]

    OppenheimerFunds Inc. decreased its position in KLX Inc (NASDAQ:KLXI) by 16.2% in the 1st quarter, Holdings Channel reports. The firm owned 7,067 shares of the aerospace company’s stock after selling 1,367 shares during the period. OppenheimerFunds Inc.’s holdings in KLX were worth $502,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Rich Smith]

    KLX Inc. (NASDAQ:KLXI) stock closed 15.2% lower on Monday. That sounds like bad news, but really isn’t. Here’s why.

    So what

    KLX is a strange beast, as it comprises two main business units. The Aerospace Solutions Group distributes small airplane components such as bolts, clips, hinges, and screws. With $1.4 billion in annual sales, this is KLX’s largest business unit — and it’s selling out to Boeing in a $4.25 billion deal initially expected to close sometime in this current third quarter of 2018  — later postponed to Q4.

  • [By Shane Hupp]

    KLX (NASDAQ:KLXI) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Friday.

  • [By Max Byerly]

    BidaskClub downgraded shares of KLX (NASDAQ:KLXI) from a buy rating to a hold rating in a report released on Tuesday morning.

    KLXI has been the subject of several other reports. SunTrust Banks cut shares of KLX from a buy rating to a hold rating and set a $53.00 target price for the company. in a report on Wednesday, May 2nd. Zacks Investment Research cut shares of KLX from a buy rating to a hold rating in a report on Saturday, February 17th. TheStreet cut shares of KLX from a b rating to a c+ rating in a report on Tuesday, March 6th. Finally, Jefferies Group upgraded shares of KLX from a hold rating to a buy rating in a report on Wednesday, March 7th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $66.50.

Top 10 Undervalued Stocks To Watch For 2019: Discover Financial Services(DFS)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    Over the past several quarters, Discover Financial Services (NYSE:DFS) has struggled to strike the proper balance between growing its loan portfolios and keeping its credit default risks in check. At least, that’s what Wall Street would have you believe. Discover’s management, however, maintains credit risk concerns are overblown. Meanwhile, the company continues to grow its loan portfolios at steady clips.

  • [By Joseph Griffin]

    DFS Furniture (LON:DFS)‘s stock had its “buy” rating reissued by analysts at Peel Hunt in a research note issued to investors on Thursday.

  • [By ]

    Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .

    Inflation Is a Key Risk

    Execs were most worried about inflation, as they should be.

Top 10 Undervalued Stocks To Watch For 2019: Gulfport Energy Corporation(GPOR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Liberty Mutual Group Asset Management Inc. lowered its stake in Gulfport Energy Co. (NASDAQ:GPOR) by 22.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,452 shares of the oil and gas producer’s stock after selling 9,320 shares during the quarter. Liberty Mutual Group Asset Management Inc.’s holdings in Gulfport Energy were worth $313,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Gulfport Energy (NASDAQ: GPOR) and Callitas Health (OTCMKTS:MPHMF) are both small-cap oils/energy companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.

  • [By Shane Hupp]

    Gulfport Energy Co. (NASDAQ:GPOR) saw some unusual options trading activity on Monday. Stock investors bought 43,045 call options on the stock. This is an increase of approximately 1,866% compared to the typical volume of 2,190 call options.

  • [By Max Byerly]

    Liberum Capital reissued their hold rating on shares of Great Portland Estates (LON:GPOR) in a research note published on Wednesday morning.

    GPOR has been the subject of a number of other reports. Barclays increased their price objective on shares of Great Portland Estates from GBX 560 ($7.51) to GBX 580 ($7.78) and gave the company an underweight rating in a report on Thursday, February 22nd. Deutsche Bank reaffirmed a hold rating on shares of Great Portland Estates in a report on Friday, March 2nd. Goldman Sachs Group cut their price objective on shares of Great Portland Estates from GBX 675 ($9.06) to GBX 665 ($8.92) and set a neutral rating for the company in a report on Wednesday, March 14th. Morgan Stanley increased their price objective on shares of Great Portland Estates from GBX 620 ($8.32) to GBX 660 ($8.86) and gave the company an underweight rating in a report on Tuesday, March 13th. Finally, Citigroup raised their target price on shares of Great Portland Estates from GBX 700 ($9.39) to GBX 735 ($9.86) and gave the company a neutral rating in a report on Wednesday, May 2nd. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. Great Portland Estates has a consensus rating of Hold and a consensus target price of GBX 662.15 ($8.88).

  • [By Logan Wallace]

    Gulfport Energy Co. (NASDAQ:GPOR) – Stock analysts at Seaport Global Securities upped their Q3 2018 earnings per share estimates for Gulfport Energy in a research note issued on Wednesday, May 23rd. Seaport Global Securities analyst M. Kelly now expects that the oil and gas producer will post earnings of $0.33 per share for the quarter, up from their prior estimate of $0.22. Seaport Global Securities also issued estimates for Gulfport Energy’s Q4 2018 earnings at $0.43 EPS, FY2018 earnings at $1.63 EPS, Q2 2019 earnings at $0.28 EPS, Q3 2019 earnings at $0.28 EPS, Q4 2019 earnings at $0.35 EPS and FY2019 earnings at $1.22 EPS.

  • [By Paul Ausick]

    Gulfport Energy Corp. (NASDAQ: GPOR) traded down about 10% Tuesday and posted a new 52-week low of $10.90 after closing Monday at $12.12. The stock’s 52-week high is $9.75. Volume was over 12 million, nearly four times the daily average of about 3.4million shares. The company had no specific news announced its capital budget and a stock repurchase program after markets closed Monday.

Top 10 Undervalued Stocks To Watch For 2019: ITUS Corporation(ITUS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ITUS Corp (NASDAQ:ITUS) CEO Amit Kumar bought 4,480 shares of ITUS stock in a transaction dated Wednesday, September 12th. The shares were purchased at an average cost of $3.99 per share, for a total transaction of $17,875.20. Following the completion of the transaction, the chief executive officer now owns 128,888 shares of the company’s stock, valued at approximately $514,263.12. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Top 10 Undervalued Stocks To Watch For 2019: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Ultragenyx Pharmaceutical alerts:

    Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)

    A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.

  • [By Shane Hupp]

    Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ultragenyx launched its second drug, Crysvita, in the United States to treat X-linked hypophosphatemia (XLH) in April. We are optimistic on the drug’s uptake. The drug was also approved in the EU in February on a conditional basis. In May, the company announced positive phase II data from the drug in pediatric setting, but according to the FDA those were not sufficient to support an NDA. Thus, the company is in discussions with FDA and EMA, which would provide further clarity regarding whether an additional study would be required for the approval. The company also remains focused on its two-gene therapy programs — DTX301 for ornithine transcarbamylase deficiency and DTX401 for glycogen storage disease type Ia. However, developmental or regulatory setbacks could result in higher operating expenses and the need for additional capital. Loss estimates have narrowed ahead of  Q3 earnings release.”

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

Top 10 Undervalued Stocks To Watch For 2019: Cytosorbents Corporation(CTSO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cytosorbents Corp (NASDAQ:CTSO) COO Vincent Capponi sold 9,565 shares of the company’s stock in a transaction that occurred on Tuesday, August 28th. The shares were sold at an average price of $13.00, for a total value of $124,345.00. Following the completion of the transaction, the chief operating officer now owns 342,333 shares in the company, valued at approximately $4,450,329. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Motley Fool Transcribers]

    Cytosorbents Corp  (NASDAQ:CTSO)Q4 2018 Earnings Conference CallMarch 07, 2019, 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Cytosorbents (NASDAQ:CTSO) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday.

Top 10 Undervalued Stocks To Watch For 2019: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wall Street seemed to phone it in on Monday, with low volume and fairly modest moves for most major benchmarks reflecting the fact that many federal and state government offices were closed for a holiday. Interest rates stabilized after a substantial jump last week, but market participants are still working through the potential consequences of the rate rise that resulted in 10-year Treasury yields hitting their highest levels since the early 2010s. Moreover, some negative news regarding individual companies weighed on sentiment. Square (NYSE:SQ), Ebix (NASDAQ:EBIX), and iRobot (NASDAQ:IRBT) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Motley Fool Transcribers]

    Ebix Inc  (NASDAQ:EBIX)Q4 2018 Earnings Conference CallMarch 01, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Shares of Ebix Inc (NASDAQ:EBIX) were down 5.8% during mid-day trading on Tuesday . The stock traded as low as $57.66 and last traded at $61.47. Approximately 18,499 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 189,931 shares. The stock had previously closed at $58.10.

  • [By Shane Hupp]

    Ebix (NASDAQ: EBIX) and Godaddy (NYSE:GDDY) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

  • [By Shane Hupp]

    Shares of Ebix Inc (NASDAQ:EBIX) have been assigned a consensus recommendation of “Buy” from the six ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $100.00.

  • [By Ethan Ryder]

    Ebix (NASDAQ:EBIX) issued its earnings results on Wednesday. The technology company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.01), MarketWatch Earnings reports. The business had revenue of $108.23 million for the quarter, compared to analysts’ expectations of $106.81 million. Ebix had a return on equity of 20.67% and a net margin of 27.65%. Ebix’s revenue for the quarter was up 36.8% on a year-over-year basis.

Top 10 Undervalued Stocks To Watch For 2019: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wall Street started the week on a muted note on Monday, as major benchmarks generally closed slightly down. Much of the attention among investors was on the bond market, where 10-year Treasury yields rose as high as 2.99%, signaling to some the possibility of much higher financing costs that could punish companies that overextended their balance sheets with debt when rates were much lower. Yet some individual companies had good news that sent their shares higher. McDermott International (NYSE:MDR), Box (NYSE:BOX), and Hanesbrands (NYSE:HBI) were among the best performers on the day. Here’s why they did so well.

  • [By Stephan Byrd]

    Morgan Stanley increased its position in shares of Hanesbrands Inc. (NYSE:HBI) by 13.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,095,675 shares of the textile maker’s stock after acquiring an additional 362,960 shares during the period. Morgan Stanley owned about 0.86% of Hanesbrands worth $68,166,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Hanesbrands (HBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Hanesbrands (HBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Noonan]

    The strategy might not produce huge gains overnight, but patient investors can see strong returns with a value-focused, buy-to-hold approach to dividend stocks. Within that mold, investors seeking solid, income-generating stocks should consider establishing or adding to positions in Hanesbrands (NYSE:HBI) and AT&T (NYSE:T) — two companies that are consistently profitable, trade at non-prohibitive valuations, and pay sizable dividends. 

  • [By Keith Noonan]

    For this dive into promising income-generating stocks, I’ll be looking at three companies that have recently been making headlines for their strong performances. Two are technology giants that are benefiting from the growth of recurring revenue streams — Cisco Systems (NASDAQ:CSCO) and Microsoft (NASDAQ:MSFT) — and the other is an apparel stalwart on the rebound as one of its key lines is heating up — Hanesbrands (NYSE:HBI).

Top 10 Undervalued Stocks To Watch For 2019: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    1ST RES BK EXTO/SH (OTCMKTS:FRSB) and First of Long Island (NASDAQ:FLIC) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “First of Long Island Corp (FLIC) Position Trimmed by ClariVest Asset Management LLC” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/4167612/first-of-long-island-corp-flic-position-trimmed-by-clarivest-asset-management-llc.html.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First of Long Island (FLIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    First of Long Island Corp (NASDAQ:FLIC) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $21.30 and last traded at $21.60, with a volume of 237 shares. The stock had previously closed at $21.50.

  • [By Stephan Byrd]

    First of Long Island (NASDAQ:FLIC) and 1ST RES BK EXTO/SH (OTCMKTS:FRSB) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Hot Gold Stocks For 2019

This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30)
DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24%
Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98%
Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56%
Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73%
Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89%
Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27%
Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25%
Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16%
Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75%
Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%

Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

Hot Gold Stocks For 2019: International Tower Hill Mines Ltd(THM)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Hot Gold Stocks For 2019: ConAgra Foods, Inc.(CAG)

Advisors’ Opinion:

  • [By Max Byerly]

    Change (CURRENCY:CAG) traded up 8.4% against the U.S. dollar during the twenty-four hour period ending at 21:00 PM Eastern on April 20th. One Change token can now be purchased for approximately $0.21 or 0.00002362 BTC on popular cryptocurrency exchanges including EtherDelta and Kucoin. Change has a total market cap of $7.72 million and approximately $56,746.00 worth of Change was traded on exchanges in the last day. In the last seven days, Change has traded up 26.7% against the U.S. dollar.

  • [By Chris Lange]

    Conagra Brands Inc. (NYSE: CAG) is expected to release its most recent quarterly report early Thursday. The consensus forecast calls for $0.55 in EPS on $2.0 billion in revenue. Shares closed at $36.61 on Friday. The consensus target price is $42.21, and shares have changed hands between $32.16 and $41.63 in the past year.

  • [By Shane Hupp]

    Rhumbline Advisers reduced its stake in shares of Conagra Brands (NYSE:CAG) by 4.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 744,090 shares of the company’s stock after selling 34,068 shares during the period. Rhumbline Advisers’ holdings in Conagra Brands were worth $27,442,000 as of its most recent SEC filing.

Hot Gold Stocks For 2019: Eagle Bancorp, Inc.(EGBN)

Advisors’ Opinion:

Hot Gold Stocks For 2019: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ebix (NASDAQ: EBIX) and Mattersight (NASDAQ:MATR) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

  • [By Ethan Ryder]

    Ebix (NASDAQ:EBIX) issued its earnings results on Wednesday. The technology company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.01), MarketWatch Earnings reports. The business had revenue of $108.23 million for the quarter, compared to analysts’ expectations of $106.81 million. Ebix had a return on equity of 20.67% and a net margin of 27.65%. Ebix’s revenue for the quarter was up 36.8% on a year-over-year basis.

  • [By Shane Hupp]

    ARS Investment Partners LLC boosted its position in shares of Ebix Inc (NASDAQ:EBIX) by 62.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92,910 shares of the technology company’s stock after acquiring an additional 35,681 shares during the quarter. ARS Investment Partners LLC owned 0.30% of Ebix worth $6,922,000 at the end of the most recent quarter.

Hot Tech Stocks To Invest In Right Now

The health care sector was in trouble over the past year, coming under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could be different for this sector, but after President-elect Trumps recent comments that this industry was getting away with murder, the future is uncertain. In Thursdays trading session health care stocks were somewhat muted, but a few bucked this trend.

24/7 Wall St. has picked out some of the biggest moves in the sector that stood out from the rest on Thursday. We have included information about each company, as well as recent trading activity and the consensus price target.

Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

Hot Tech Stocks To Invest In Right Now: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Hot Tech Stocks To Invest In Right Now: Rackspace Hosting Inc(RAX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.

Hot Tech Stocks To Invest In Right Now: SuperCom, Ltd.(SPCB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Supercom Ltd (NASDAQ: SPCB) shares shot up 53 percent to $4.17 after the company reported strong results for its third quarter. SuperCom expects FY17 sales of at least $35 million.

  • [By Monica Gerson]

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Hot Tech Stocks To Invest In Right Now: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap insurance software stock Ebix Inc (NASDAQ: EBIX) reported Q1 2017 earnings before the market opened this morning. Q1 revenue rose 11% to $79.1 million and decreased 1% over Q4 2016 revenue of $80.0 million. The year over year revenue improvement reflected growth in the Companys Exchange, Risk Compliance, and Broker Solution channels. On a constant currency basis, Q1 revenue increased 10% to $78.5 millionwith theExchange channel continued to bethe Companyslargest -accounting for 67% of Q1 2017 revenues. Q1 2017 net income rose 19% to $26.4 million with the improvement principally reflected the benefit of higher revenues and operating income as compared to the same period last year.

Hot Tech Stocks To Invest In Right Now: Wipro Limited(WIT)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.